Twenty years on, survivors of testicular cancer still have large amounts of
platinum circulating in their blood, from their chemotherapy. A team from the
University of Groningen in the Netherlands examined 61 men who had been treated
with the platinum-containing drug cisplatin. Between 10 and 20 years later the
men had an average of 65 picograms per gram of plasma. Among 20 controls, who
survived testicular cancer without chemotherapy, 18 had no platinum and two had
only traces (The Lancet, vol 355, p 1075). The team says the drug’s
persistence justifies research into long-term side effects.
To continue reading, today with our introductory offers
Advertisement
More from Âé¶¹´«Ã½
Explore the latest news, articles and features
Popular articles
Trending Âé¶¹´«Ã½ articles
1
Neanderthal infants were enormous compared with modern humans
2
Exclusive report: Inside Chernobyl, 40 years after nuclear disaster
3
The biggest threat to Chernobyl is no longer radiation
4
A key solution to climate change isn't happening – and that's good
5
How autoimmune conditions can unexpectedly drive mental illness
6
The man who crawls into the perilous heart of the Chernobyl reactor
7
Electric vehicle owners could earn thousands by supporting power grid
8
Largest ever map of universe captures 47 million galaxies and quasars
9
The best new popular science books of April 2026
10
Startling images show how fake news isn't just a 21st century issue



